These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3117000)

  • 21. [Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism].
    Chamontin B; Begasse F; David D; Salvador M
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1237-40. PubMed ID: 2510655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
    Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose captopril as a diagnostic test for primary aldosteronism.
    Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
    J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    Clin Chem; 2020 Mar; 66(3):483-492. PubMed ID: 32068832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production.
    Nakamaru M; Misono KS; Naruse M; Workman RJ; Inagami T
    Endocrinology; 1985 Nov; 117(5):1772-8. PubMed ID: 3899615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
    Wisgerhof M; Mellinger RC
    J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of the captopril screening test for primary aldosteronism.
    Naomi S; Iwaoka T; Umeda T; Inoue J; Hamasaki S; Miura F; Fujii Y; Sato T
    Jpn Heart J; 1985 Jul; 26(4):549-56. PubMed ID: 3903249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG; Espiner EA; Donald RA
    J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsiveness of plasma aldosterone to angiotensin II in patients with diabetes mellitus.
    Morimoto S; Uchida K; Kigoshi T; Hosojima H; Yamamoto I; Azukizawa S
    Endocrinol Jpn; 1983 Oct; 30(5):671-8. PubMed ID: 6368211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
    Baba T; Aoyagi K; Murabayashi S; Sasaki K; Nigawara K; Takebe K
    Endocrinol Jpn; 1983 Dec; 30(6):715-21. PubMed ID: 6327249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is single oral administration of captopril beneficial in screening for primary aldosteronism?
    Muratani H; Abe I; Tomita Y; Ueno M; Kawazoe N; Kimura Y; Tsuchihashi T; Takishita S; Uezono K; Kawasaki T
    Am Heart J; 1986 Aug; 112(2):361-7. PubMed ID: 3526854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of single-dose captopril test in the differential diagnosis of primary aldosteronism].
    Ustinova SE; Uchitel' IA; Sokolova RI; Popov VA
    Kardiologiia; 1990 Oct; 30(10):85-8. PubMed ID: 2290281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does the captopril test improve the diagnosis of primary hyperaldosteronism?].
    Wambach G; Degenhardt S; Bönner G; Stimpel M; Grimm U; Krone W
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1175-80. PubMed ID: 1644014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
    Whitfield L; Sowers JR; Tuck ML; Golub MS
    J Clin Endocrinol Metab; 1980 Oct; 51(4):724-9. PubMed ID: 6252224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.